Aeglea BioTherapeutics Holds 7.1 Million Cash With SVB
| AGLEDelisted Stock | USD 0.59 0.01 1.72% |
About 54% of Aeglea Bio's shareholders are presently thinking to get in. The analysis of current outlook of investing in Aeglea Bio Therapeutics suggests that some traders are interested regarding Aeglea Bio's prospects. The current market sentiment, together with Aeglea Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Aeglea Bio Therapeutics stock news signals to limit their universe of possible portfolio assets.
Aeglea |
By Will Feuer Aeglea BioTherapeutics Inc. said it holds about 7.1 million of cash deposits with the collapsed Silicon Valley Bank, including a 1 million...
Read at marketwatch.com
 |
Aeglea Bio Fundamental Analysis
We analyze Aeglea Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aeglea Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aeglea Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Aeglea Bio is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Aeglea Bio Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aeglea Bio stock to make a market-neutral strategy. Peer analysis of Aeglea Bio could also be used in its relative valuation, which is a method of valuing Aeglea Bio by comparing valuation metrics with similar companies.
Peers
Aeglea Bio Related Equities
| TIL | Instil Bio | 16.79 | ||||
| ASMB | Assembly Biosciences | 10.72 | ||||
| ALRN | Aileron Therapeutics | 7.03 | ||||
| CTMX | CytomX Therapeutics | 6.25 | ||||
| NUVB | Nuvation Bio | 3.21 | ||||
| XLO | Xilio Development | 2.02 | ||||
| SNTI | Senti Biosciences | 1.42 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| IKNA | Ikena Oncology | 1.17 | ||||
| BNTC | Benitec Biopharma | 1.22 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| DSGN | Design Therapeutics | 2.93 | ||||
| CING | Cingulate | 3.67 | ||||
| BPTH | Bio Path | 3.75 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Aeglea Stock
If you are still planning to invest in Aeglea Bio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeglea Bio's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world |